Skip to main content

Table 3 Effect of non-CSD on rates of overall survival

From: Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis

Variable

 

At 10 years (%)

  

At 15 years (%)

 
 

non-CSD

(n = 1754)

ACD

(n = 5055)

non-CSD/ACD

non-CSD

(n = 2422)

ACD

(n = 5909)

non-CSD/ACD

Total

9.5%

27.3%

0.35

13.8%

33.5%

0.41

Ages, year

 20–39 (Youngest)

3.1%

13.3%

0.23

5.1%

16.7%

0.31

 40–59 (Older)

9.9%

27.8%

0.36

16.7%

37.3%

0.45

  ≥ 60 (Oldest)

29.8%

72.5%

0.41

38.2%

83%

0.46

Period

 1983–1992

11.4%

32.6%

0.35

15.6%

39.1%

0.40

 1993–2000

9.4%

26.9%

0.35

13.3%

32.3%

0.41

 2001–2005

8.5%

24.6%

0.35

13.3%

30.7%

0.43

Sex

 Male

11.1%

31%

0.36

16.3%

38.2%

0.43

 Female

7.6%

23%

0.33

10.8%

27.8%

0.39

Race

 White

9.6%

26.8%

0.36

13.9%

32.9%

0.42

 Black

9%

32.4%

0.28

13.4%

38.4%

0.35

 Others

8.5%

27.8%

0.31

12.2%

33.7%

0.36

Marital status

 Married

10.1%

26.8%

0.38

14.8%

33.6%

0.44

 Unmarried

8.8%

27.9%

0.32

12.7%

33.4%

0.38

Histological type

 NS

7.2%

21.9%

0.33

10.9%

27.2%

0.40

 MC

15.9%

41.9%

0.38

21.9%

50.4%

0.43

 LR

13%

28.8%

0.45

20.2%

39.1%

0.52

 LD

16.5%

65.9%

0.25

20.6%

72.0%

0.29

Stage

 Early stage

8.7%

21.4%

0.41

13.0%

27.2%

0.48

 Advanced stage

11.2%

38.7%

0.29

15.1%

44.3%

0.34

Therapy

 Combined modality

5.2%

15.1%

0.34

9.1%

20.6%

0.44

 RT only

11.3%

22.2%

0.51

16.7%

29.3%

0.57

 CT only

10.9%

35.1%

0.31

15.1%

41.3%

0.37

 No/unknown

13.0%

37.9%

0.34

16.5%

42.6%

0.39

  1. CSD cancer-specific death, ACD all causes of deaths, NS nodular sclerosis, MC mixed cellularity, LR lymphocyte-rich, LD lymphocyte-depletion